Visura Technologies
- Industry
- Medical Devices & Instruments
- Founded Year
- 2015
- Headquarters
- 8400 Normandale Lake Blvd, Suite 920, Bloomington, MN 55437
- Employee Count
- 6
Key People
- Christine Horton - President & CEO
- David Marmor - Founder & Chief Marketing Officer
- Jodi Lamberti - Vice President of Commercial Development
- Michael Clarke - Director of Professional Education
- Andrea R. - Vice President of Commercial Operations
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team comprises experienced professionals with significant industry experience.
The leadership team includes individuals with over a decade of experience in the medical device industry, enhancing the company's credibility and operational effectiveness.
- Clinical Need
-
Aspect: Very Strong
Summary: The TEECAD System addresses a critical need for safer and more efficient TEE probe intubations.
By providing real-time visualization during TEE probe intubations, the TEECAD System reduces the risk of complications, meeting a pressing clinical need.
- Competition
-
Aspect: First mover
Summary: Visura Technologies is the first to market with an FDA-cleared disposable camera for TEE probes.
The lack of direct competitors in this niche allows Visura to establish a strong market presence and brand recognition.
- Technical Challenge
-
Aspect: Predictable
Summary: The development of the TEECAD System involves manageable technical challenges.
The integration of a disposable camera with TEE probes requires precision engineering, but the challenges are within the company's capabilities.
- Patent
-
Aspect: Strong
Summary: Visura Technologies holds strong patents for its TEECAD System.
The company's patents protect its innovative technology, preventing competitors from easily replicating the product.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding, including a $4 million Series B round.
The Series B financing, led by a strategic investor, enables Visura to expand its commercial operations and market reach.
- Regulatory
-
Aspect: 510k/PMA
Summary: The TEECAD System has received FDA 510(k) clearance.
Achieving 510(k) clearance demonstrates the product's safety and efficacy, allowing for commercialization in the U.S. market.
Opportunity Rollup
- Odds of Success
- 4.3
- Peak Market Share
- 6.3
- Segment CAGR
- 4.4%
- Market Segment
- Cardiovascular Devices
- Market Sub Segment
- Diagnostic Imaging
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.32 |
| 2 | 0.94 |
| 3 | 2.20 |
| 4 | 4.41 |
| 5 | 6.30 |
Key Takeaway
Visura Technologies' TEECAD System addresses a critical clinical need with innovative technology, positioning the company for significant growth in the cardiovascular device market.